Intellia Therapeutics, Inc. - Common Stock (NTLA)
$10.90
0.19 (1.77%)
7 CRISPR Stocks for the Future of Medicine
Between these seven genetic editing pioneers, you have the widest exposure to the biggest scientific breakthrough of the century.

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
960.74M
PE Ratio
-2.00
EPS
-5.44
Volume (Avg. Vol.)
351,551
Day's Range
$10.70 - $11.03
52-Week Range
$8.96 - $34.87
Dividend & Yield
N/A (N/A)